57 results on '"Zolty, R."'
Search Results
2. (448) - Exploring the Potential: GLP-1 Receptor Agonists for Advanced Therapies in End-Stage Heart Failure
3. (452) Recurrent Enteroviral Myocarditis in Transplanted Heart from Induced Immune Deficiency
4. Sacubitril/Valsartan Improves Outcomes in Left Ventricular Assist Device Recipients
5. Impact of mTOR Inhibitor Conversion Protocol on Renal Function in Cardiac Transplant Recipients
6. Safety and Efficacy of SGLT2i Post Orthotopic Heart Transplantation
7. Incidence of mTORi Associated BOOP in Cardiac Transplant Recipients – A Single Center Perspective
8. The Impact of Evolocumab in Cardiac Transplant Patients with Coronary Allograft Vasculopathy
9. First Results of Soprano: Macitentan in Patients (pts) with Pulmonary Hypertension (PH) Post-Left Ventricular Assist Device (LVAD) Implantation
10. Pre-Heart Transplant Spirometry Predicts Post-Transplant Survival
11. The Effect of Exercise on Endothelin 1 Level in Patients with Pulmonary Hypertension
12. Impact of Heart Rate and Left Ventricular Mass on Survival Following Heart Transplantation
13. Impact of Heart Rate and Left Ventricular Mass on Survival Following Heart Transplantation
14. Comparison of Endothelin-1 Level in Group I Pulmonary Hypertension vs. Group II Pulmonary Hypertension Both at Rest and at Peak Exercise
15. Pre-Operative Ventilatory Inefficiency is Associated with Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices
16. (163) - Pre-Operative Tricuspid Regurgitation and Right Ventricular Enlargement are Associated with Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices
17. (917) - Cardiopulmonary Stress Test One Year After HTx Predicts the Development of CAV
18. (911) - Higher Heart Rate Is Associated with Lower Incidence of Coronary Allograft Vasculopathy Requiring Angioplasty
19. (1207) - The Transmitral Peak Flow Velocity-Mitral Annular Diastolic Velocity Ratio (e/e') Does Not Predict Left Ventricular Filling Pressure Post Cardiac Transplant
20. (1113) - Left Ventricular Assist Device Improves Type II Pulmonary Hypertension with High Pulmonary Vascular Resistance
21. (1033) - Psychosocial Factors and Outcomes with Left Ventricular Assist Device Therapy
22. (1013) - Depression in Patients Undergoing Left Ventricular Assist Device Implantation
23. (1087) - Oxydative Stress in Heart Failure Patients after Implantation of Continuous Flow Left Ventricular Assist Devices
24. (1043) - Myocarditis Treated with VA-ECMO: A Single Centers Experience
25. (822) - Cardiac Allograft Sinus Tachycardia Is Associated with Impaired Exercise Tolerance
26. (778) - CMV Reactivation Using Valganciclovir vs Valacyclovir in Moderate Risk Heart Transplant Recipients
27. (748) - Heart Failure Patients’ Quality of Life and Perception of Palliative Care
28. (526) - Heart Rate and Cardiac Allograft Vasculopathy in Heart Transplant Recipients
29. (547) - Mineralocorticoid Receptor Antagonists Enhance Cardiac Function during Continuous Flow Left Ventricular Assist Device Support
30. (751) - Left Ventricular Internal Diastolic Diameter as a Predictor of Outcomes in Ischemic Cardiomyopathy
31. (388) - Differentiating Heart Failure with Preserved Ejection Fraction Induced Pulmonary Hypertension from Pulmonary Hypertension Using Demographic Data and Common Blood Measurements
32. (387) - Heart Failure with Preserved Ejection Fraction Induced Reactive Pulmonary Hypertension Lacks Nitric Oxide Vasoreactivity Similar to Pulmonary Arterial Hypertension
33. (146) - Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin- Receptor Blockers (ARBs) during CF-LVAD Support Are Associated with Sustained Improvement in Renal Function
34. (44) - Intracranial Hemorrhage Is Associated with a Higher Doppler Blood Pressure during Continuous Flow Left Ventricular Assist Device Support
35. 838 Differences in Mortality and Morbidity in Pulmonary Hypertension Secondary to Systolic vs. Diastolic Heart Failure
36. 833 Effect of Obesity on Mortality in Pulmonary Arterial Hypertension: A Retrospective Analysis
37. 621 Endothelin-1 Levels in Pulmonary Hypertension: A Comparison between Pulmonary Arterial Hypertension and Diastolic Heart Failure-Induced Pulmonary Hypertension
38. 616 Bradykinin Targeted Therapy Decreases Mortality in Pulmonary Hypertension
39. 430 The Role of Cardiac Biomarkers in Takotsubo Cardiomyopathy
40. 678 Dose-Dependent Improvement in Survival with ACE Inhibitor Use in Patients with Pulmonary Arterial Hypertension and Heart Failure with Normal Ejection Fraction
41. 503 Anti-Inflammatory Drugs Improve Mortality in Pulmonary Hypertension
42. 504 Improved Survival with Pioglitazone in Patients with Diabetes Mellitus, Pulmonary Arterial Hypertension and Heart Failure with Normal Ejection Fraction: A Comparative Effectiveness Analysis
43. 499 Improved Survival with Statin Use in Patients with Pulmonary Arterial Hypertension and Heart Failure with Normal Ejection Fraction
44. 313 Effect of Nesiritide on Renal Function in Patients with Decompensated Diastolic Heart Failure Secondary to Pulmonary Hypertension
45. 310 Hypoalbuminemia Is a Predictor of Mortality in Pulmonary Arterial Hypertension: A Retrospective Analysis
46. 309 Mortality in Pulmonary Hypertension Stratified by Sedimentation Rate
47. 308 Role of Inflammation in Patients with Both Pulmonary Hypertension and Atrial Fibrillation
48. 215 Higher Doses of Spirinolactone Are Associated with Lower Survival in Patients with Congestive Heart Failure
49. 214 Improved Survival with Sustained Release Metoprolol When Compared to Carvedilol in Patients with Ischemic Heart Failure: A Comparative Effectiveness Analysis
50. 21 Relaxin Levels Elevated in Patients with Pulmonary Arterial Hypertension
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.